Unitedhealth, Warren Buffett and stock act
Digest more
The company may be under criminal investigation for alleged irregularities in its Medicare business—but it's been touched by the Warren Buffett effect.
1don MSN
UnitedHealth Stock Is Having Its Best Day in Years. It Still Needs More to Cure Its Problems.
UNH stock soared after Warren Buffett’s Berkshire Hathaway revealed it bought shares of the healthcare company. Nonetheless, UnitedHealth faces a long list of unresolved issues.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Year to date, the stock has fallen by nearly 45%, which is by no means normal for the healthcare stock. In fact, this is the worst it has performed since the Great Recession, when it tumbled by more than 54% in 2008.
Shares of UnitedHealth Group surged nearly 14% on Friday after billionaire Warren Buffett's Berkshire Hathaway bought 5 million shares of the company, providing a shot in the arm for investors who think the health conglomerate will turn around under its new CEO.
UnitedHealth's yield is typically less than 2%, but nowadays, it's well over 3%. The stock experienced a steep decline in value this year as its financials underwhelmed investors. Rising costs, utilization rates,
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
2don MSN
Watch These UnitedHealth Price Levels as Stock Jumps After Buffett's Berkshire Reveals Stake
Key Takeaways UnitedHealth Group shares surged Friday after Warren Buffett’s Berkshire Hathaway revealed a stake in the embattled healthcare giant.After bottoming at the start of August, the stock has continued to gain momentum,
Warren Buffett's modus operandi is to wait for price dislocations to present themselves. In a historically pricey stock market, locating value has been virtually impossible. Yet, with UnitedHealth Group stock losing more than half its value since the midpoint of April, a rare price dislocation has emerged.
2d
Axios on MSNUnitedHealth is unpopular, but its stock suddenly isn't
UnitedHealth Group's public reputation is still reeling, yet its battered stock has been something that more and more investors can't seem to resist. Why it matters: Recent interest in its stock, from everyday investors to Wall Street's titans,